SEC Form 4 · accession 0001193125-26-271363
Medline Inc. · MDLN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Todd M Bluedorn
Director
Period of report
Dec 16, 2025
Accepted (ET)
Jun 15, 2026 · 5:50 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0002046386
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Dec 16, 2025 | A | 10,345 | $0.00 | A | 10,345 | D | |
| Class A Common Stock | Jun 11, 2026 | A | 5,387 | $0.00 | A | 15,732 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents a grant of restricted stock units ("RSUs") that vest on March 30, 2027. These securities were previously reported on the Reporting Person's Form 3 filed on December 17, 2025.
- F2Represents a grant of RSUs that vest on the earlier of (i) the first anniversary of the date of grant, and (ii) the next annual meeting of stockholders following the date of grant.